Drug Type Small molecule drug |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Contineum Therapeutics, Inc.Startup |
Active Organization Contineum Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuroinflammation | Phase 1 | US | Contineum Therapeutics, Inc.Startup | 03 Apr 2022 |